Research Article

Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice

Figure 1

Effects of ginsenoside Rg1 (Rg1) on blood glucose and body weight in type 1 diabetes (T1D) mice. (a) The time axis of animal treatment. (b, c) Changes in blood glucose and body weight on days 7, 8, 9, and 15 since the first injection of streptozotocin (SZT). (d, e) The statistical analysis of blood glucose and body weight in different groups on days 15 since the first injection of SZT. Those results suggested the T1D mouse models were successfully constructed, and Rg1 treatment improved blood glucose and body weight in T1D. (Mean ± SD, n = 6) , vs. the control group; Δ, vs. the Rg1 group; #, ## vs. the DM group.
(a)
(b)
(c)
(d)
(e)